U.S. markets closed

Outset Medical, Inc. (OM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.33+2.73 (+4.91%)
At close: 4:00PM EDT
Full screen
Loading interactive chart...
  • Outset Medical Prices Equity Offering At $53.50 Per Share
    Benzinga

    Outset Medical Prices Equity Offering At $53.50 Per Share

    View more earnings on OMSee more from BenzingaClick here for options trades from BenzingaJ&J Seeks To Conduct Study For COVID-19 Vaccine In India: ReutersHealthEquity Scoops Up Further For 0M© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge
    Business Wire

    Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge

    The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have named Outset Medical’s Tablo Hemodialysis System® one of seven winners in Round 2 of the KidneyX COVID-19 Kidney Care Challenge, recognizing innovative solutions for safely delivering kidney care during the pandemic. Specifically designed to simplify dialysis treatment for patients and providers, Tablo is a first-of-its-kind enterprise solution that lowers the cost and complexity of dialysis and is approved for use across the entire continuum of care.

  • Outset Medical Announces Pricing of Primary and Upsized Secondary Public Offering
    Business Wire

    Outset Medical Announces Pricing of Primary and Upsized Secondary Public Offering

    Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the pricing of an underwritten public offering of 2,500,000 shares of its common stock sold by Outset and 3,444,859 shares of its common stock by certain of its stockholders at a public offering price of $53.50 per share. In addition, Outset and such selling stockholders granted the underwriters a 30-day option to purchase up to an additional 891,728 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The underwriting discounts and commissions will be borne by Outset with respect to the shares it sells in the offering and by the selling stockholders with respect to the shares they sell in the offering. The offering is expected to close on April 13, 2021, subject to the satisfaction of customary closing conditions.